Pharmaceutical companies have once again used industry influence to conceal data and make false claims about a high-profile medication.
Today The New York Times reported that Johnson & Johnson and Bayer – the companies behind the anti-clotting drug Xarelto – are responsible for critical laboratory data being left out of a letter published in The New England Journal of Medicine discussing the safety of the medication. Lawyers representing patients suing the two major pharmaceutical companies claim that both corporations were complicit by remaining silent about the data concealed from the publication.
